Guelph, ON ZEN Graphene Solutions Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN and OTC:ZENYF) is pleased to announce the following related to its proprietary, graphene-based coating…2021
Continue Reading
ZEN Graphene Solutions and TreborRx Announce Nitrile Glove Agreement and Provide Health Canada Update
Guelph, ON ZEN Graphene Solutions Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN and OTC:ZENYF) is pleased to announce the following related to its proprietary, graphene-based coating…2021
Continue Reading
ZEN Graphene Solutions Announces New Team Members to Support Current Opportunities and Future Growth
Guelph, ON ZEN Graphene Solutions Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN and OTC:ZENYF) is pleased to announce the addition of the following individuals to its…2021
Continue Reading
ZEN Graphene Solutions Announces Initial Phase 2 Cytotoxicity Results for Its Graphene-Based Compound
Guelph, ON – ZEN Graphene Solutions Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN and OTC:ZENYF) is pleased to announce very promising initial phase 2 results of…2021
Continue Reading
ZEN Graphene Solutions Named to the TSX Venture 50
Guelph, ON ZEN Graphene Solutions Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN and OTC:ZENYF), a next-gen nanomaterials technology company, is pleased to announce that it has…2021
Continue Reading
ZEN Graphene Solutions Announces Successful Phase 2 Cytotoxicity Testing Results
Guelph, ON ZEN Graphene Solutions Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN and OTC:ZENYF), a next-gen nanomaterials technology company, is pleased to announce successful phase 2 results from cytotoxicity testing of its graphene-based compound. Nucro-Technics recorded no adverse effects after seven days of repeated dosing with concentrations many thousands…2021
Continue Reading